Dwyer JP - Search Results

1

Phosphorus binding with ferric citrate is associated with fewer hospitalizations and reduced hospitalization costs.

Rodby R, Umanath K, Niecestro R, Jackson JH, Sika M, Lewis JB, Dwyer JP; Collaborative Study Group. Rodby R, et al. Among authors: dwyer jp. Expert Rev Pharmacoecon Outcomes Res. 2015 Jun;15(3):545-50. doi: 10.1586/14737167.2015.995169. Epub 2014 Dec 13. Expert Rev Pharmacoecon Outcomes Res. 2015. PMID: 25495878 Clinical Trial.

2

Evaluation of renal artery stenosis in dialysis patients.

Dwyer JP, Greco BA, Lewis JB. Dwyer JP, et al. Semin Dial. 2009 Sep-Oct;22(5):519-23. doi: 10.1111/j.1525-139X.2009.00618.x. Epub 2009 Jun 25. Semin Dial. 2009. PMID: 19558627 Review.

3

Proteinuria in type 2 diabetic patients with renal impairment: the changing face of diabetic nephropathy.

Packham DK, Ivory SE, Reutens AT, Wolfe R, Rohde R, Lambers Heerspink H, Dwyer JP, Atkins RC, Lewis J; Collaborative Study Group. Packham DK, et al. Among authors: dwyer jp. Nephron Clin Pract. 2011;118(4):c331-8. doi: 10.1159/000323139. Epub 2011 Feb 3. Nephron Clin Pract. 2011. PMID: 21293156 Clinical Trial.

4

Olmesartan to prevent the development of microalbuminuria: is it new? Is it true? Is it important?

Dwyer JP, Lewis JB. Dwyer JP, et al. Am J Kidney Dis. 2011 Nov;58(5):700-3. doi: 10.1053/j.ajkd.2011.07.001. Epub 2011 Jul 29. Am J Kidney Dis. 2011. PMID: 21802806 No abstract available.

5

Relative incidence of ESRD versus cardiovascular mortality in proteinuric type 2 diabetes and nephropathy: results from the DIAMETRIC (Diabetes Mellitus Treatment for Renal Insufficiency Consortium) database.

Packham DK, Alves TP, Dwyer JP, Atkins R, de Zeeuw D, Cooper M, Shahinfar S, Lewis JB, Lambers Heerspink HJ. Packham DK, et al. Among authors: dwyer jp. Am J Kidney Dis. 2012 Jan;59(1):75-83. doi: 10.1053/j.ajkd.2011.09.017. Epub 2011 Nov 3. Am J Kidney Dis. 2012. PMID: 22051245

6

Renal Dysfunction in the Presence of Normoalbuminuria in Type 2 Diabetes: Results from the DEMAND Study.

Dwyer JP, Parving HH, Hunsicker LG, Ravid M, Remuzzi G, Lewis JB. Dwyer JP, et al. Cardiorenal Med. 2012 Feb;2(1):1-10. doi: 10.1159/000333249. Epub 2011 Oct 26. Cardiorenal Med. 2012. PMID: 22493597 Free PMC article.

7

Rationale and study design of a three-period, 58-week trial of ferric citrate as a phosphate binder in patients with ESRD on dialysis.

Umanath K, Sika M, Niecestro R, Connelly C, Schulman G, Koury MJ, Lewis JB, Dwyer JP; Collaborative Study Group. Umanath K, et al. Among authors: dwyer jp. Hemodial Int. 2013 Jan;17(1):67-74. doi: 10.1111/j.1542-4758.2012.00711.x. Epub 2012 Jun 15. Hemodial Int. 2013. PMID: 22702490 Clinical Trial.

8

In-center thrombolysis for clotted AV access: a cohort review.

Umanath K, Morrison RS, Christopher Wilbeck J, Schulman G, Bream P, Dwyer JP. Umanath K, et al. Among authors: dwyer jp. Semin Dial. 2013 Jan-Feb;26(1):124-9. doi: 10.1111/j.1525-139X.2012.01105.x. Epub 2012 Jul 12. Semin Dial. 2013. PMID: 22784240 Review.

9

The safety and tolerability of ferric citrate as a phosphate binder in dialysis patients.

Sinsakul M, Sika M, Koury M, Shapiro W, Greene T, Dwyer J, Smith M, Korbet S, Lewis J; Collaborative Study Group. Sinsakul M, et al. Nephron Clin Pract. 2012;121(1-2):c25-9. doi: 10.1159/000341922. Epub 2012 Oct 16. Nephron Clin Pract. 2012. PMID: 23075669 Clinical Trial.

10

Nonproteinuric diabetic nephropathy: when diabetics don't read the textbook.

Dwyer JP, Lewis JB. Dwyer JP, et al. Med Clin North Am. 2013 Jan;97(1):53-8. doi: 10.1016/j.mcna.2012.10.006. Epub 2012 Nov 27. Med Clin North Am. 2013. PMID: 23290729 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

112 results

Search Page